Jaime Westlund, NP
Nurse Practitioner · Kailua Kona, HINPI 1730744640
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,563 of the $1,808 with a category attached, or 86.5%. 18 manufacturers reported payments, led by AbbVie at 32.3% of the total. Reporting peaked in 2023 at $923 and has fallen 89.3% since, to $99 in 2025.
Across 70 payments — averaging $25.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$584
- Amgen$193
- Boston Scientific$192
- Pfizer$140
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$109
- AstraZeneca$102
- plus $488 from 12 others
What the payments were for
- Travel & lodging$24514%
- Food & beverage$1,56386%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $584 |
| Amgen | 10 | $193 |
| Boston Scientific | 8 | $192 |
| Pfizer | 8 | $140 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $109 |
| AstraZeneca | 5 | $102 |
| Merck | 4 | $73 |
| Bayer | 4 | $68 |
| Irhythm Technologies, Inc. | 2 | $55 |
| Novartis | 3 | $55 |
| Lexicon Pharmaceuticals, Inc. | 3 | $52 |
| Boehringer Ingelheim | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Baxter Healthcare | 2 | $30 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Novo Nordisk | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
How this compares
$1,808 in reported general payments places this provider in the 85th percentile of 215 nurse practitioner providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $119,845 |
| EntrestoSacubitril/Valsartan | 64 | $103,386 |
| JardianceEmpagliflozin | 31 | $50,382 |
| XareltoRivaroxaban | 37 | $49,363 |
| FarxigaDapagliflozin Propanediol | 15 | $15,846 |
| Metoprolol Succinate | 184 | $3,288 |
| Olmesartan Medoxomil | 64 | $2,623 |
| Atorvastatin Calcium | 107 | $2,186 |
| Ezetimibe | 25 | $1,287 |
| Bumetanide | 29 | $1,043 |
| Rosuvastatin Calcium | 42 | $895 |
| Potassium Chloride | 22 | $685 |
| Warfarin Sodium | 56 | $609 |
| Spironolactone | 70 | $579 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $528 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $140 | $119,84579 claims |
| NovartisEntresto | $55 | $103,38664 claims |
| Boehringer IngelheimJardiance | $44 | $50,38231 claims |
| Johnson & JohnsonXarelto | $17 | $49,36337 claims |
| AstraZenecaFarxiga | $102 | $15,84615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 215 nurse practitioner providers in Hawaii.
Other nurse practitioner in Kailua Kona
- Jenny EadsKailua Kona$756
- Kimi PrenticeEwa Beach$65K
- Ashley SpringerHonolulu$43K
- Sung JungHonolulu$29K
- Judy KoHonolulu$17K
- Joanna AgenaAiea$16K
- Rosemarie ForondaWailuku$15K
- Bryce MontalboHonolulu$15K
- Anitalei AlexioAiea$11K
- Rita AbreuHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.